Stock H1SI34 HENRY SCHEIN, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Henry Schein, Inc. Sao Paulo

Equities

H1SI34

BRH1SIBDR001

Medical Equipment, Supplies & Distribution

Market Closed - Sao Paulo
Other stock markets
 09:44:18 2024-04-09 am EDT 		5-day change 1st Jan Change
180.7 BRL -4.29% Intraday chart for Henry Schein, Inc. -.--% -0.10%
Jun. 05 Transcript : Henry Schein, Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:00 AM
May. 30 Transcript : Henry Schein, Inc. Presents at Stifel Jaws & Paws Conference, May-30-2024 10:20 AM

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,749 9,400 10,810 10,826 9,838 8,773 - -
Enterprise Value (EV) 1 10,400 9,678 11,564 11,858 12,018 10,723 10,471 10,308
P/E ratio 14.3 x 23.3 x 17.5 x 20.4 x 24 x 17.6 x 14.4 x 12.9 x
Yield - - - - - - - -
Capitalization / Revenue 0.98 x 0.93 x 0.87 x 0.86 x 0.8 x 0.66 x 0.63 x 0.6 x
EV / Revenue 1.04 x 0.96 x 0.93 x 0.94 x 0.97 x 0.8 x 0.75 x 0.7 x
EV / EBITDA 11.3 x 12.9 x 10.8 x 12.4 x 12.2 x 9.58 x 8.59 x 7.91 x
EV / FCF 18 x 17.6 x 18.3 x 23.4 x 34 x 18.6 x 16 x 14.1 x
FCF Yield 5.56% 5.68% 5.45% 4.27% 2.94% 5.38% 6.26% 7.11%
Price to Book 3.18 x 2.8 x 3.12 x 3.05 x 2.68 x 1.97 x 1.72 x 1.52 x
Nbr of stocks (in thousands) 146,740 142,776 138,674 135,548 129,938 128,051 - -
Reference price 2 66.44 65.84 77.95 79.87 75.71 68.51 68.51 68.51
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,986 10,119 12,401 12,647 12,339 13,346 14,019 14,704
EBITDA 1 917.9 752.9 1,069 959 984 1,119 1,218 1,303
EBIT 1 733 567.4 859.6 747 615 824.1 912.6 999.2
Operating Margin 7.34% 5.61% 6.93% 5.91% 4.98% 6.18% 6.51% 6.79%
Earnings before Tax (EBT) 1 680.3 499.9 830.5 721 542 771.6 923.4 975.3
Net income 1 694.7 403.8 631.2 538 416 520.1 642.3 723.4
Net margin 6.96% 3.99% 5.09% 4.25% 3.37% 3.9% 4.58% 4.92%
EPS 2 4.650 2.820 4.450 3.910 3.160 3.895 4.754 5.322
Free Cash Flow 1 577.9 550.1 630.6 506 353 577 655 732.5
FCF margin 5.79% 5.44% 5.08% 4% 2.86% 4.32% 4.67% 4.98%
FCF Conversion (EBITDA) 62.95% 73.06% 58.98% 52.76% 35.87% 51.55% 53.76% 56.23%
FCF Conversion (Net income) 83.18% 136.23% 99.89% 94.05% 84.86% 110.93% 101.98% 101.26%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 3,331 3,179 3,030 3,067 3,371 3,060 3,100 3,162 3,017 3,172 3,271 3,377 3,530 3,343 3,410
EBITDA 1 263.8 299 273 263 124 257 250 259 172 255 280.7 296.3 301.3 271 304.2
EBIT 1 205.1 244 220 211 72 175 201 200 39 150 211.7 224.3 234.8 196.5 229.7
Operating Margin 6.16% 7.68% 7.26% 6.88% 2.14% 5.72% 6.48% 6.33% 1.29% 4.73% 6.47% 6.64% 6.65% 5.88% 6.74%
Earnings before Tax (EBT) 1 193 239 214 205 63 163 186 179 14 127 196.6 208.5 222.4 202.2 230.3
Net income 1 147.2 181 160 150 47 121 140 137 18 93 139.2 149.3 159.4 145.3 163
Net margin 4.42% 5.69% 5.28% 4.89% 1.39% 3.95% 4.52% 4.33% 0.6% 2.93% 4.26% 4.42% 4.52% 4.35% 4.78%
EPS 2 1.050 1.300 1.160 1.090 0.3400 0.9100 1.060 1.050 0.1300 0.7200 0.9900 1.102 1.177 1.116 1.231
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 2/15/22 5/3/22 8/2/22 11/1/22 2/16/23 5/9/23 8/7/23 11/13/23 2/27/24 5/7/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 651 278 755 1,032 2,180 1,950 1,698 1,535
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 0.7088 x 0.3689 x 0.7058 x 1.076 x 2.215 x 1.742 x 1.394 x 1.178 x
Free Cash Flow 1 578 550 631 506 353 577 655 733
ROE (net income / shareholders' equity) 23.3% 12.7% 18.6% 18.2% 16.7% 15.2% 15.1% 14.2%
ROA (Net income/ Total Assets) 8.88% 5.41% 7.88% 8.67% 6.18% 6.18% 6.67% 6.77%
Assets 1 7,826 7,462 8,008 6,205 6,731 8,411 9,635 10,693
Book Value Per Share 2 20.90 23.50 25.00 26.10 28.30 34.70 39.90 45.20
Cash Flow per Share 2 4.380 4.180 5.010 4.370 3.800 7.100 5.630 -
Capex 1 76.2 48.8 79 96 147 125 116 121
Capex / Sales 0.76% 0.48% 0.64% 0.76% 1.19% 0.94% 0.83% 0.82%
Announcement Date 2/20/20 2/17/21 2/15/22 2/16/23 2/27/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Henry Schein, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
68.51 USD
Average target price
79.42 USD
Spread / Average Target
+15.92%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Equipment Wholesale

1st Jan change Capi.
SHIP HEALTHCARE HOLDINGS, INC. Stock Ship Healthcare Holdings, Inc.
+1.58% 1.47B
OWENS & MINOR, INC. Stock Owens & Minor, Inc.
-9.91% 1.33B
AS ONE CORPORATION Stock AS ONE Corporation
-4.89% 1.22B
GKHT MEDICAL TECHNOLOGY CO., LTD. Stock GKHT Medical Technology Co., Ltd.
-26.95% 766M
TOKAI CORP. Stock TOKAI Corp.
+1.67% 459M
EXCELSIOR MEDICAL CO., LTD. Stock Excelsior Medical Co., Ltd.
+1.70% 431M
GAUSH MEDITECH LTD Stock Gaush Meditech Ltd
-62.86% 266M
COWEALTH MEDICAL CHINA CO.,LTD. Stock Cowealth Medical China Co.,Ltd.
-32.42% 299M
WIN-PARTNERS CO., LTD. Stock WIN-Partners Co., Ltd.
-0.08% 218M
Medical Equipment Wholesale
  1. Stock Market
  2. Equities
  3. HSIC Stock
  4. H1SI34 Stock
  5. Financials Henry Schein, Inc.